Sorcero vs Veeva Systems (2026)
Both bring AI to life sciences companies, and they sit in different places in the organization. Sorcero, based in Washington, DC, builds for medical affairs, scientific communications and pharmacovigilance. Its platform draws on more than 265 million publications, trials and congress abstracts alongside a customer's CRM records, medical inquiries and safety cases, and its agents check each output against the source text and cite the sentence behind it. Sorcero Safety, built with Springer Nature, monitors the literature for adverse events. Veeva's Vault is the cloud platform more than 1,500 life sciences customers run across clinical, regulatory, safety, quality, medical and commercial work. Vault AI Agents are built into those applications, released three times a year and run on Anthropic and Amazon models on Amazon Bedrock, and Veeva publishes its subprocessors and says customer data never trains those models. If your failure mode is a medical affairs or safety team without a literature and insight platform of its own, start with Sorcero. If it is AI that has to run inside the validated system the company already uses, under the same permissions and audit logging, start with Veeva.
- It works across more than 265 million publications, trials and congress abstracts together with the customer's CRM records, medical inquiries and safety cases, and cites the source sentence behind each insight.
- Sorcero SciComms drafts manuscripts, posters and plain language summaries, and a 2025 study in JAMIA Open, run with UCB and Lumanity, found its plain language drafts cut medical writers' drafting time by more than 40 percent.
- Sorcero Safety monitors literature for adverse events and reads from safety databases including Oracle Argus, ArisGlobal ArisG and Veeva Safety, with device vigilance added through the 2025 acquisition of Axiom Health.
- Vault AI Agents cover call notes, voice capture, pre call preparation, promotional content review and regulatory, safety and quality work, and act only with the permissions the customer assigns, with every action logged.
- Its subprocessor list names Amazon Web Services, Anthropic, Google Gemini, OpenAI and Eleven Labs with purpose and processing location, and its trust page says customer data is never used to train those models.
- The Study Builder Agent, announced in September 2026 for early adopters in December, configures Veeva EDC and DQS from a protocol and is included with EDC.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Sorcero and Veeva Systems are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Sorcero | Veeva Systems |
|---|---|---|
| Primary category | Clinical Trials AI | Clinical Trials AI |
| Headquarters | Washington, District of Columbia | Pleasanton, California |
| Website | sorcero.com | veeva.com |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
Sorcero
-
Product / capability
Sorcero's Fall 2026 release adds purpose built AI solutions for field medical, medical communications, and therapeutic leadership and launch teams, plus a Medical Strategy solution for tracking scientific resonance.
Source
Veeva Systems
-
Product / capability
Veeva's Vault AI release AI.2642 opens the Query Agent to programmatic use through the Vault API and MCP, without a person in the loop, and lowers its token use.
Source -
Product / capability
Veeva announced Study Builder Agent, which configures Veeva EDC forms, visits and edit checks and Veeva DQS listings directly from a study protocol, reusing an organization's existing standards and the CDISC USDM model, and generates test data.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Washington, DC company whose AI and data platform serves the medical side of life sciences: medical affairs, scientific communications and pharmacovigilance. Sorcero Medical covers field medical insights, congress and publication intelligence and, from the Fall 2026 release, a Medical Strategy solution and the Wizard conversational assistant in beta; Sorcero SciComms generates manuscripts, posters and plain language summaries; Sorcero Safety, built with Springer Nature, monitors literature for adverse events.
Source: AI Health Index, August 2026
Pleasanton, California provider of Vault, the cloud platform life sciences companies use across clinical, regulatory, safety, quality, medical and commercial work, with more than 1,500 customers. Vault AI Agents are built into Veeva applications and released three times a year: commercial agents for call notes, voice capture, pre-call preparation and promotional content review, and agents in regulatory, safety and quality applications, running on Anthropic and Amazon models on Amazon Bedrock.
Source: AI Health Index, August 2026
Questions buyers ask
How do Sorcero and Veeva Systems work with the EHR?
Sorcero Safety lists internal sources including safety databases (Oracle Argus, ArisGlobal ArisG and Veeva Safety), clinical reports, lab results and patient registries, alongside Springer Nature literature and more than 50 global and local sources. The medical products ingest CRM records and medical inquiry logs, with no CRM system named.
Vault AI Agents operate inside Veeva applications with direct access to their data and documents, through the Vault interface or API, and customers can configure them or build custom agents. The Study Builder Agent configures Veeva EDC and Veeva DQS from a protocol using the CDISC Unified Study Definitions Model and is delivered as a Claude Cowork plugin from a Veeva-managed GitHub repository. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
How are Sorcero and Veeva Systems priced and sold?
In Sorcero's case, the company pairs the platform with high-touch services from Insights Leads and Deployment Strategists, so an engagement is software plus services; Medical, SciComms and Safety are separate product suites on one platform.
For Veeva Systems, enterprise agreements with life sciences companies are scoped by application and users across the Vault suite. The Study Builder Agent is part of EDC and requires no additional license. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
How do Sorcero and Veeva Systems handle patient data?
With Sorcero, the data is sensitive in a different way from patient records: safety cases, medical inquiries, CRM interactions and profiles of identifiable clinicians built from publications and congress activity.
In Veeva Systems' case, the content is sensitive: call notes record interactions with named healthcare professionals and can contain incidental patient details, and voice capture runs through Eleven Labs for speech services. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Trials AI page.
Neither publishes a price. Sorcero offers its SOC 2 Type II report and penetration test results through its trust center and says its GxP, Part 11 and GDPR compliance is independently audited. Veeva is audited against ISO/IEC 27001, 27017 and 27018, holds a SOC 2 Type II report and provides a validation summary report on request.
Sorcero's figures of near zero hallucinations and more than 96 percent accuracy carry no reference set or method, and no Veeva agent has a published accuracy or time result. Falcon, Veeva's set of standard agents for clinical, regulatory, safety and MLR work, is announced for early adopters from November 2026 and not yet available.